Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net income	$ 23,461,508	$ 12,976,216
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(4,787)	55,126
Realized investment gains, net	(3,548,793)	(975,769)
Change in fair value of equity securities	(28,213,466)	(16,290,482)
Change in allowance from credit losses	(15,000)	0
Amortization of cost of insurance acquired	152,537	153,542
Provision for deferred income taxes	4,739,351	3,750,347
Depreciation and depletion	494,447	375,893
Stock-based compensation	178,321	13,974
Charges for mortality and administration of universal life and annuity products	(1,332,337)	(1,354,014)
Interest credited to account balances	848,659	872,357
Change in accrued investment income	(13,025)	184,152
Change in reinsurance receivables	(2,621,734)	277,737
Change in policy liabilities and accruals	2,851,835	(1,523,417)
Change in income taxes receivable	1,521,280	47,948
Change in other assets and liabilities, net	(1,097,667)	(1,818,821)
Net cash used in operating activities	(2,598,871)	(3,255,211)
Proceeds from investments sold and matured:
Fixed maturities available for sale	2,242,178	3,000,000
Equity securities	16,110,094	2,331,830
Mortgage loans	1,228,381	1,096,597
Notes receivable	455,703	95,403
Policy loans	245,920	248,124
Short-term investments	2,500,000	0
Total proceeds from investments sold and matured	22,782,276	6,771,954
Cost of investments acquired:
Fixed maturities available for sale	(1,706,386)	0
Equity securities	(717,988)	(9,131,704)
Mortgage loans	(441,906)	(675,112)
Notes receivable	0	(1,318,133)
Real estate	0	(465,800)
Policy loans	(151,876)	(202,355)
Total cost of investments acquired	(3,018,156)	(11,793,104)
Net cash (used in) provided by investing activities	19,764,120	(5,021,150)
Cash flows from financing activities:
Policyholder contract deposits	1,013,884	1,025,008
Policyholder contract withdrawals	(1,748,500)	(1,158,017)
Purchase of treasury stock	(195,773)	(96,024)
Net cash used in financing activities	(930,389)	(229,033)
Net increase (decrease) in cash and cash equivalents	16,234,860	(8,505,394)
Cash and cash equivalents at beginning of period	30,536,972	45,263,967
Cash and cash equivalents at end of period	$ 46,771,832	$ 36,758,573